Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth
J Caverzasio, C Thouverey - Cellular Physiology and Biochemistry, 2011 - karger.com
Abstract Background/Aims: Strontium ranelate (SrRan) is an anti-osteoporotic treatment that
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.
J Caverzasio, C Thouverey - Cellular Physiology and Biochemistry …, 2011 - europepmc.org
Methods MC3T3-E1 and primary osteoblastic cells, specific inhibitors of receptor tyrosine
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth
J Caverzasio, C Thouverey - Cellular Physiology and Biochemistry, 2011 - hero.epa.gov
Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces the risk of vertebral
and hip fractures. Recent in vitro studies suggest that the effect of strontium ranelate on …
and hip fractures. Recent in vitro studies suggest that the effect of strontium ranelate on …
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.
J Caverzasio, C Thouverey - Cellular physiology and biochemistry …, 2011 - sonar.ch
METHODS MC3T3-E1 and primary osteoblastic cells, specific inhibitors of receptor tyrosine
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
[PDF][PDF] Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth
J Caverzasio, C Thouverey - Cell Physiol …, 2011 - access.archive-ouverte.unige.ch
Abstract Background/Aims: Strontium ranelate (SrRan) is an anti-osteoporotic treatment that
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth.
J Caverzasio, C Thouverey - Cellular Physiology & …, 2011 - search.ebscohost.com
Abstract Background/Aims: Strontium ranelate (SrRan) is an anti-osteoporotic treatment that
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect …
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth
J Caverzasio, C Thouverey - Cellular physiology and …, 2011 - pubmed.ncbi.nlm.nih.gov
Background/aims Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces
the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of …
the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of …
[PDF][PDF] Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth
J Caverzasio, C Thouverey - Cellular Physiology and Biochemistry, 2011 - karger.com
Background/Aims: Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces
the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of …
the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of …
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.
J Caverzasio, C Thouverey - Cellular physiology and biochemistry …, 2011 - folia.unifr.ch
METHODS MC3T3-E1 and primary osteoblastic cells, specific inhibitors of receptor tyrosine
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
kinases (RTK) and western blot analysis were used to characterize the CaSR-independent …
[引用][C] Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth
J Caverzasio, C Thouverey - Cellular Physiology and Biochemistry, 2011 - cir.nii.ac.jp
Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces
Osteoblastic Cell Growth | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Osteoblastic Cell Growth | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …